<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Ge C</submitter><funding>National Natural Science Foundation of China</funding><pubmed_abstract>Vaccination is considered one of the most effective methods for preventing avian influenza. The influenza neuraminidase (NA) enzyme is a promising candidate for a conserved influenza vaccine, offering long-term and effective cross-protection against the disease. The aim of this study is to develop a &lt;i>Salmonella&lt;/i>-vectored vaccine with strong protective efficacy against H9N2 avian influenza virus. We utilized the antibiotic-free balanced-lethal system of regulated delayed-lysis &lt;i>Salmonella&lt;/i> (χ11218) as the starting strain to construct a &lt;i>focA&lt;/i> gene-deleted &lt;i>Salmonella&lt;/i> (χYL57) strain. To optimize the vaccine design, we fused a tetravalent NA protein (tetramer-NA) with a chicken dendritic cell-targeting peptide (chDCpep) and delivered it via χ11218 or χYL57, yielding the c</pubmed_abstract><journal>Microbiology spectrum</journal><pagination>e0142125</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12671097</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Protection against H9N2 challenge in chickens via &amp;lt;i&amp;gt;Salmonella&amp;lt;/i&amp;gt; with a &amp;lt;i&amp;gt;focA&amp;lt;/i&amp;gt; mutation delivered by a dendritic cell-targeted avian influenza virus NA protein tetramer.</pubmed_title><pmcid>PMC12671097</pmcid><funding_grant_id>32072897</funding_grant_id><pubmed_authors>Ge C</pubmed_authors><pubmed_authors>Zhang G</pubmed_authors><pubmed_authors>Wang C</pubmed_authors><pubmed_authors>Huang H</pubmed_authors><pubmed_authors>Jia F</pubmed_authors><pubmed_authors>Sun Y</pubmed_authors><pubmed_authors>Guo Q</pubmed_authors><pubmed_authors>Wang M</pubmed_authors><pubmed_authors>Jiang Y</pubmed_authors><pubmed_authors>Zhang T</pubmed_authors><pubmed_authors>He Y</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Tian Y</pubmed_authors><pubmed_authors>Gao Y</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Yang T</pubmed_authors><pubmed_authors>Gong J</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Protection against H9N2 challenge in chickens via &amp;lt;i&amp;gt;Salmonella&amp;lt;/i&amp;gt; with a &amp;lt;i&amp;gt;focA&amp;lt;/i&amp;gt; mutation delivered by a dendritic cell-targeted avian influenza virus NA protein tetramer.</name><description>Vaccination is considered one of the most effective methods for preventing avian influenza. The influenza neuraminidase (NA) enzyme is a promising candidate for a conserved influenza vaccine, offering long-term and effective cross-protection against the disease. The aim of this study is to develop a &lt;i>Salmonella&lt;/i>-vectored vaccine with strong protective efficacy against H9N2 avian influenza virus. We utilized the antibiotic-free balanced-lethal system of regulated delayed-lysis &lt;i>Salmonella&lt;/i> (χ11218) as the starting strain to construct a &lt;i>focA&lt;/i> gene-deleted &lt;i>Salmonella&lt;/i> (χYL57) strain. To optimize the vaccine design, we fused a tetravalent NA protein (tetramer-NA) with a chicken dendritic cell-targeting peptide (chDCpep) and delivered it via χ11218 or χYL57, yielding the c</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-06-05T22:05:55.998Z</modification><creation>2026-05-22T03:15:41.99Z</creation></dates><accession>S-EPMC12671097</accession><cross_references><pubmed>41143405</pubmed><doi>10.1128/spectrum.01421-25</doi></cross_references></HashMap>